Thyroxine-binding globulin (TBG), the principal thyroid hormone transp
ort protein in human serum, is synthesized by the liver and secreted i
nto the bloodstream as a 54-kD acidic glycoprotein made up of a single
polypeptide chain of 395 amino acids and four heterosaccharide units.
The carbohydrate chains are important for the correct posttranslation
al folding, secretion and degradation of the molecule but are not requ
ired for hormone binding. TBG, encoded by a single gene copy located o
n Xq22, consists of five exons spanning 5.5 kbp. An upstream sequence
of 218 nucleotides containing a hepatocyte nuclear factor 1 binding mo
tif imparts to the gene a strong liver-specific transcriptional activi
ty. Inherited TBG defects produce three phenotypes based on the level
of TBG in serum of affected hemizygotes: complete TBG deficiency (TBG-
CD), partial TBG deficiency (TBG-PD) and TBG excess (TBG-E). The molec
ular basis of the TBG defect has been identified in 12 of 16 known TBG
variants. TBG-CD is caused by either premature termination of transla
tion or an amino acid substitution resulting in failure of secretion.
Point mutations resulting in single amino acid substitutions are respo
nsible for the alteration of the properties and/or concentration of TB
G-PD variants. Gene duplication and triplication has been recently ide
ntified in subjects with TBG-E.